Jonathan Kil
Directeur Général chez Sound Pharmaceuticals, Inc.
Profil
Jonathan Kil is the founder.
He founded Otogene in 1998 and Sound Pharmaceuticals, Inc. in 2002, where he currently holds the title of Director, Chief Executive & Medical Officer.
Dr. Kil has a doctorate degree from the University of Virginia and an undergraduate degree from the University of California, Irvine.
Postes actifs de Jonathan Kil
| Sociétés | Poste | Début |
|---|---|---|
Sound Pharmaceuticals, Inc.
 Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Directeur Général | 01/02/2002 |
Anciens postes connus de Jonathan Kil
| Sociétés | Poste | Fin |
|---|---|---|
| Otogene | Fondateur | - |
Formation de Jonathan Kil
| University of Virginia | Doctorate Degree |
| University of California, Irvine | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Sound Pharmaceuticals, Inc.
Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Health Technology |
| Otogene |